Literature DB >> 3872884

Purification and partial characterization of a megakaryocyte colony-stimulating factor from human plasma.

R Hoffman, H H Yang, E Bruno, J E Straneva.   

Abstract

Human plasma obtained from patients with hypomegakaryocytic thrombocytopenia contains a factor that promotes megakaryocyte colony formation by normal human marrow cells. This megakaryocyte colony-stimulating factor was purified from such a plasma specimen. A four-step purification scheme which included ammonium sulfate precipitation, diethylaminoethyl-Sepharose chromatography, affinity chromatography on wheat germ lectin-Sepharose 6MB, and reverse-phase high performance liquid chromatography resulted in a recovery of 16.6% of the initial biological activity and an increase in specific activity by 3,489-fold. The purified protein produced a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Purified megakaryocyte colony-stimulating factor was capable of promoting megakaryocyte colony formation at a concentration of 7.6 X 10(-8) M. Megakaryocyte colony-stimulating factor was shown to be a glycoprotein and had an apparent 46,000 mol wt. Deglycosylation of megakaryocyte colony-stimulating factor by treatment with trifluoromethane-sulfonate resulted in the loss of its ability to promote megakaryocyte colony formation. Megakaryocyte colony-stimulating factor appears to be an important regulator of in vitro human megakaryocytopoiesis at the level of the colony-forming unit megakaryocyte and may be of importance physiologically.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872884      PMCID: PMC425442          DOI: 10.1172/JCI111813

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Thrombopoietin production by human embryonic kidney cells in culture.

Authors:  T P McDonald; R Clift; R D Lange; C Nolan; I I Tribby; G H Barlow
Journal:  J Lab Clin Med       Date:  1975-01

2.  Induction of megakaryocyte colonies with platelet formation in vitro.

Authors:  D L McLeod; M M Shreve; A A Axelrad
Journal:  Nature       Date:  1976-06-10       Impact factor: 49.962

3.  Improved plasma culture system for production of erythrocytic colonies in vitro: quantitative assay method for CFU-E.

Authors:  D L McLeod; M M Shreeve; A A Axelrad
Journal:  Blood       Date:  1974-10       Impact factor: 22.113

4.  Studies of leukemic cell populations in culture.

Authors:  M T Aye; Y Niho; J E Till; E A McCulloch
Journal:  Blood       Date:  1974-08       Impact factor: 22.113

5.  Isolation of vitamin B12-binding proteins using affinity chromatography. II. Purification and properties of a human granulocyte vitamine B12-binding protein.

Authors:  R H Allen; P W Majerus
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

6.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Purification and properties of colony-stimulating factor from mouse lung-conditioned medium.

Authors:  A W Burgess; J Camakaris; D Metcalf
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

9.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

10.  Thrombopoietic activity of fractions of rabbit plasma: studies in rabbits and mice.

Authors:  B L Evatt; D P Shreiner; J Levin
Journal:  J Lab Clin Med       Date:  1974-03
View more
  14 in total

1.  Purification of a membrane-derived human erythroid growth factor.

Authors:  L Feldman; C M Cohen; M A Riordan; N Dainiak
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  PEGylation prevents the N-terminal degradation of megakaryocyte growth and development factor.

Authors:  P I Guerra; C Acklin; A A Kosky; J M Davis; M J Treuheit; D N Brems
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

Review 3.  Recent developments in ex vivo platelet production.

Authors:  Retno Wahyu Nurhayati; Yoshihiro Ojima; Masahito Taya
Journal:  Cytotechnology       Date:  2016-03-22       Impact factor: 2.058

4.  Studies of human megakaryocytopoiesis using an anti-megakaryocyte colony-stimulating factor antiserum.

Authors:  H H Yang; E Bruno; R Hoffman
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

Review 5.  Characterization of hematopoietic stem and progenitor cells.

Authors:  D E Williams; L Lu; H E Broxmeyer
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 6.  Significance of polyploidy in megakaryocytes and other cells in health and tumor disease.

Authors:  M Winkelmann; P Pfitzer; W Schneider
Journal:  Klin Wochenschr       Date:  1987-12-01

7.  Synergistic regulation of human megakaryocyte development.

Authors:  M W Long; R J Hutchinson; L L Gragowski; C H Heffner; S G Emerson
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

8.  Immunocytochemical identification of murine and human megakaryocyte colonies in soft-agar cultures.

Authors:  J L Zhang; P E Stenberg; G Baker; J Levin
Journal:  Histochem J       Date:  1994-02

9.  Increased biological activity of deglycosylated recombinant human granulocyte/macrophage colony-stimulating factor produced by yeast or animal cells.

Authors:  P Moonen; J J Mermod; J F Ernst; M Hirschi; J F DeLamarter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

10.  Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia.

Authors:  J L Nichol; M M Hokom; A Hornkohl; W P Sheridan; H Ohashi; T Kato; Y S Li; T D Bartley; E Choi; J Bogenberger
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.